क्यूआर कोड

Cardiovascular Toxicity of Novel HER2-Targeted Agents and Multikinase Inhibitors in Oncology: From Mechanisms to Real-World Clinical Evidence

The advent of novel Human Epidermal growth factor Receptor 2 (HER2)-targeted therapies and tyrosine kinase inhibitors (TKIs) has significantly improved outcomes in HER2-positive malignancies, particularly breast cancer. However, these agents carry a growing burden of cardiovascular adverse events, r...

पूर्ण विवरण

में बचाया:
मुख्य लेखकों: Amro Abu Suleiman, Vincenzo Quagliariello, Luigi Spadafora, Federico Russo, Nicola Maurea
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: MDPI AG 2026-05-01
श्रृंखला:Pharmaceuticals
विषय:
cardio-oncology
cardiotoxicity
HER2
targeted therapy
heart failure
trastuzumab
ऑनलाइन पहुंच:https://www.mdpi.com/1424-8247/19/6/833
टैग: टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन